What is the principle behind intravenous lipid emulsion therapy in severe drug overdoses?

• A. Provides lipid nutrition to the patient to support survival
• B. Acts as a lipid sink to sequester lipophilic toxins, reducing tissue distribution and toxicity
• C. Neutralizes toxins via enzymatic degradation
• D. Enhances hepatic metabolism of toxins

Answer: (B)

The main idea is that intravenous lipid emulsion therapy creates an intravascular lipid phase that acts as a lipid sink for lipophilic toxins. By sequestering these drugs into the lipid phase, the free concentration of the toxin in plasma and tissues drops, reducing its distribution to critical organs and its toxic effects. This redistribution can lessen cardiac and central nervous system toxicity and improve clinical status. There can also be secondary benefits, such as providing fatty acids that may help cardiac function, but the primary mechanism is trapping the lipophilic toxin in the lipid compartment so it’s less available to cause harm. It does not enzymatically degrade the toxin, nor does it directly increase hepatic metabolism of the toxin.